APIE Therapeutics Welcomes Jim Greenwood to its Board of Directors
Cary, NC, March 21, 2023 (GLOBE NEWSWIRE) -- APIE Therapeutics (APIE Tx), a preclinical pharmaceutical company pioneering novel and proprietary drugs to activate the apelin receptor (APJ), announced the appointment of Jim Greenwood , former president & CEO of the Biotechnology Innovation Organization (BIO), to its board of directors.
- Cary, NC, March 21, 2023 (GLOBE NEWSWIRE) -- APIE Therapeutics (APIE Tx), a preclinical pharmaceutical company pioneering novel and proprietary drugs to activate the apelin receptor (APJ), announced the appointment of Jim Greenwood , former president & CEO of the Biotechnology Innovation Organization (BIO), to its board of directors.
- “We have a strong team of directors and advisors who have expertise in the development of medications for lung diseases and the care of patients.
- During his 18-year tenure as president and CEO of BIO, Jim built bipartisan support for the drug industry.
- “APIE possesses these key attributes, and that’s why I’m excited to join the team.”